Context: Aldosterone biosynthesis is regulated principally by ACTH and gene mutations as well as by angiotensin II and serum potassium. In addition, previous studies have reported the potential effects of KCNJ5 mutations in aldosterone-producing adenoma (APA) on cardiovascular diseases. However, responsiveness to ACTH in APAs according to potassium inwardly rectifying channel, subfamily J, member 5 (KCNJ5) mutations remains unknown.
P rimary aldosteronism (PA) is one of the major causes of secondary hypertension; the condition comprises two major subtypes: aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia (1) . In general, aldosterone production from the adrenal gland is regulated by angiotensin II, ACTH, and gene mutations as well as by potassium and serotonin (2) . According to PA guidelines (1, 3) , the following confirmatory tests have been recommended to diagnose the disease: saline infusion test (SIT), captopril challenge test (CCT), furosemide upright test, and fludrocortisone suppression test, all of which can assess the degree of autonomous aldosterone hypersecretion through the renin-angiotensin system (RAS). Meanwhile, APA has been reported to harbor a hyperresponsive status to ACTH (4) . Previous studies of East Asian patients demonstrated that the rapid ACTH stimulation test (AST) may differentiate APA from bilateral adrenal hyperplasia (5, 6) . Results of our previous study showed significantly decreased plasma aldosterone concentrations (PACs) after the dexamethasone suppression test (DST) among patients with unilateral PA (7) . In addition, the SIT after the DST was reported to detect the presence of hyperaldosteronism more effectively than the SIT without the DST, indicating the importance of the regulation of endogenous ACTH when the presence or absence of hyperaldosteronism is clinically evaluated (8) .
To date, somatic mutations have been identified in five different genes in APA, and their clinical and pathological characteristics have been studied (9, 10) . Among these mutations, those in potassium inwardly rectifying channel, subfamily J, member 5 (KCNJ5) are the most frequently detected in APA, especially among East Asian patients, and KCNJ5-mutated cases also represent the clinically more pronounced phenotype of PA, resulting in the increased risk of cardiovascular diseases (9, 11, 12) . We previously reported the high prevalence of KCNJ5-mutated APAs among patients who showed complete resolution of hypertension and improvement of vascular complications after adrenalectomy (13) , indicating that preoperative prediction of KCNJ5 mutation status would help clinicians determine the optimal treatment strategy for patients with PA. In addition, results of a recent study demonstrated high levels of 18-oxocortisol and high mRNA levels of CYP11B1 and CYP17, both of which were upregulated by ACTH stimulation, in KCNJ5-mutated APAs (14) . Given that CYP11B1 (a key enzyme in cortisol production) contributes to aldosterone biosynthesis by catalyzing the conversion of deoxycorticosterone to corticosterone (15) , these results indicated that the ACTH pathway could be additionally activated in KCNJ5-mutated APAs compared with KCNJ5 wild-type (WT) APAs. However, a detailed clinical evaluation of the responsiveness of aldosterone biosynthesis to ACTH in patients with KCNJ5-mutated APAs has not been reported.
In the present study, we evaluated the responsiveness of aldosterone biosynthesis to ACTH by using stimulating and suppression tests such as the SIT and DST to assess the activation status of the RAS and ACTH pathways. We also aimed to clarify differences in responsiveness to ACTH between patients who have APAs with and without KCNJ5 mutations.
Materials and Methods

Data Sources and Study Population
We performed a cross-sectional study of the clinical records of 141 patients with APA treated at the Yokohama Rosai Hospital from 2007 to 2014. This study was approved by the research ethics committee of Yokohama Rosai Hospital, with participants providing written informed consent. We included patients aged 20 years and older at the diagnosis of APA who had undergone adrenal imaging studies and surgical resection of the affected adrenal gland. Clinical diagnoses were made according to the Japan Endocrine Society (JES) guidelines (3).
Measurements
Demographic characteristics, history of hypertension, and potassium supplementation were self-reported. Weight and height were measured and used to calculate body mass index. We prescribed antihypertensive drugs (i.e., calcium channel antagonists and/or an a-blocker) to patients several weeks before blood sampling according to the JES guidelines (3). Morning (8:00 AM) and nighttime (11:00 PM) blood samples were collected after the patient had rested supine for 30 minutes. PAC (ng/dL, 3 27.7 for pmol/L) and plasma renin activity (PRA; ng/mL/h) were measured using RIA. Serum cortisol levels (F; mg/ dL, 3 27.6 for nmol/L) and ACTH levels (pg/mL, 3 0.220 for pmol/L) were measured using chemiluminescent enzyme immunoassay and electrochemiluminescent immunoassay, respectively. Urine aldosterone (mg/d, 3 2.77 for nmol/d) and urine cortisol (mg/d, 3 2.76 for nmol/d) were measured using RIA. We used the plasma aldosterone screening criterion as PAC/PRA ratio (ARR) .20 for patients with a PRA #1.2 ng/mL/h and a PAC $10 ng/dL. After that, we conducted confirmatory tests (at 8:00 AM) to diagnose PA according to the JES guidelines (3) .
The AST and DST were performed as follows: For the AST, ACTH was administered and blood samples were collected 30 and 60 minutes after administration; for the DST, 1 mg of dexamethasone was administered at 11:00 PM, and blood samples were drawn at 8:00 AM the following morning. Undetectable PRA levels (,0.1 ng/mL/h) were described as "0.05 ng/mL/h" in the statistical analyses. Tumor size was estimated using thin-section CT scans of the adrenal glands after an intravenous injection of contrast medium. We evaluated the laterality of hyperaldosteronism according to the results of the segment-selective ACTH-loading adrenal venous sampling (AVS), as previously described (7, 16) .
Genotyping of APA cases via PCR and direct sequencing
All of the APA tissue specimens were frozen in liquid nitrogen immediately after excision and maintained at 280°C until use. Mutations in KCNJ5, ATP1A1, ATP2B3, CAC-NA1D, and CTNNB1 were detected as previously described (13, 16) . The genotypes of 141 APAs were determined for the following genes: 107 for KCNJ5, one for ATP1A1, four for ATP2B3, three for CACNA1D, and one for CTNNB1; the other 25 APAs did not harbor mutations in these genes.
Immunohistochemistry
We diagnosed all the resected tumors as adrenocortical adenoma according to the histological criteria of Weiss (17) . After carefully reviewing the morphological findings on hematoxylin and eosin-stained tissue sections for the 101 available cases (excluding cases with detected mutations in other genes, such as ATP1A1, ATP2B3, CACNA1D, and CTNNB1), we performed immunohistochemistry of the following steroidogenic enzymes: CYP11B2, CYP11B1, CYP17, HSD3B1, HSD3B2, and DHEA-ST (18, 19) . We evaluated the semiquantified immunoreactivity of each steroidogenic enzyme using the following criteria based on the H-score: absent (0), weak but detectable (1+), distinct (2+), or very strong (3+) (20, 21) . To minimize interobserver variance, morphological evaluation of the predominant tumor cell subtypes was performed independently by two different pathologists (Y.Y. and H.S.). When there were discrepancies between the observations of Y.Y. and H.S. regarding the predominance of the morphological cell subtypes as well as the relative immunoreactivity of the tumors, the slides were reevaluated with double-headed light microscopy by these two observers and then judged on the basis of the light microscopic evaluation results.
ACTH receptor (melanocortin 2 receptor) mRNA expression via real-time PCR analysis
We determined the expression of glyceraldehyde 3-phosphate dehydrogenase (GAPDH; internal control) using LightCycler FastStart DNA MasterPLUS SYBR Green I (Roche Applied Science, Basel, Switzerland) for the 90 available cases (excluding those with detected mutations in other genes, such as ATP1A1, ATP2B3, CACNA1D, and CTNNB1). We then analyzed melanocortin 2 receptor (MC2R) expression using the LightCycler TaqMan Master and LightCycler 1.5 PCR apparatus (Roche Applied Science). Primers and probes were designed on the basis of published sequences (see Supplemental   Table 1 ). Standard curves were created for each step because of the possibility of different amplification efficiencies. We normalized the resulting threshold cycle values to those of GAPDH and presented the relative mRNA expression levels as foldinduction values relative to baseline. All procedures were repeated more than once to minimize potential intrinsic errors.
Statistical analyses
We classified the patients into two groups according to their KCNJ5 genotype (KCNJ5-mutated group, 107 patients; KCNJ5 WT group, 34 patients). We explored the patients' characteristics and generated descriptive statistics using the Fisher exact test or x 2 tests for categorical variables and the Mann-Whitney U test for continuous variables. To evaluate clinical aldosterone production through the RAS and ACTH pathways, we compared each endocrine parameter between the KCNJ5-mutated group and KCNJ5 WT group using the Mann-Whitney U test. We also performed a multivariable logistic regression analysis using a stepwise variable selection procedure to clarify endocrine parameters, which were associated mostly with the presence of KCNJ5 mutations. Estimates (95% CIs) are presented for interquartile range (IQR) increases in these parameters. In additional analyses, we excluded subjects with mutations in ATP1A1 (n = 1), ATP2B3 (n = 4), CACNA1D (n = 3), and CTNNB1 (n = 1) and performed the same analyses to validate our findings. Moreover, we estimated the difference in immunoreactivity of each steroidogenic enzyme between the two groups. Finally, we assessed the relationship of their immunoreactivity with the KCNJ5 genotype and endocrine parameters. All statistical analyses were performed using Stata software (version 12.1; StataCorp, College Station, TX). A P value of ,0.05 was considered statistically significant.
Results
The median age (IQR) of patients was 49 (41 to 58) years, and 39.7% were men ( Table 1 ). The KCNJ5-mutated group (n = 107) was younger and showed a higher percentage of females than the KCNJ5 WT group (n = 34). Tumor size was larger in the KCNJ5-mutated group than in the KCNJ5 WT group (P , 0.001). There were no other differences in clinical features between the two groups.
Differences in endocrine parameters between patients with mutated and WT KCNJ5
The baseline for endocrine parameters, including those relevant to responsiveness to ACTH stimulation, are summarized in Table 2A . The KCNJ5-mutated group had a higher PAC than the KCNJ5 WT group at both 8:00 AM (P , 0.001) and 11:00 PM (P , 0.01). However, a significant difference in F levels was not detected between the two groups at either 8:00 AM or 11:00 PM. The KCNJ5-mutated group showed lower ACTH levels and higher urine aldosterone levels than the KCNJ5 WT group, although the differences were not statistically significant. PACs at 30 and 60 minutes after AST were significantly higher in the KCNJ5-mutated group (P = 0.02 and P , 0.001, respectively) than in the KCNJ5 WT group. There were no significant differences in PAC after the DST despite the gap at baseline between these two groups.
After a confirmatory test for PA, we also estimated the endocrine parameters (3) that were considered relevant to responsiveness to angiotensin II stimulation (Table 2B ). The PAC after the SIT and the ARR after the CCT were higher in the KCNJ5-mutated group than in the KCNJ5 WT group. However, the PRA after the furosemide upright test was not significantly different between the two groups. Because the PAC after stimulation and/or suppression tests is affected by the PAC at baseline, we also calculated the ratio of each endocrine parameter (Table 2C ). The KCNJ5-mutated group showed higher ARR, PAC/F, and PAC/ACTH at 8:00 AM than the KCNJ5 WT group. We also observed a significantly higher PAC/F in the KCNJ5-mutated group after ACTH stimulation, which was consistent with the results of AVS (Supplemental Table 2 ). The PAC after the DST/PAC at 8:00 AM was significantly lower in the KCNJ5-mutated group. The PAC after the SIT/PAC at 8:00 AM and the ARR after the CCT/ARR at 8:00 AM were higher in that group than in the KCNJ5 WT group. b Blood samples were collected after the patients had rested supine for 30 min (except for the FUT).
c We described only results of PAC 60 min after the AST because PAC 30 min after the AST showed similar results.
Multivariable logistic regression analysis of the parameters associated with KCNJ5 genotype For multivariable logistic regression analysis, we selected tumor size, PAC after the SIT, and PAC after the DST in addition to patient's age and sex as independent variables on the basis of a stepwise variable selection procedure and prior knowledge ( Table 3 ). The results revealed that a larger tumor size, higher PAC after the SIT, and lower PAC after the DST were independently related to the KCNJ5 genotype. The significant inverse association between the PAC after the DST and the KCNJ5 genotype remained after adjusting for additional parameters, demonstrating robust associations with the presence of KCNJ5 mutations (i.e., PAC at 8:00 AM and PAC 60 minutes after the AST) in the previously mentioned model (Supplemental Table 3 ); however, we preferred the original model because this additional model has a risk of collinearity. The multivariable logistic regression analysis using ratios of endocrine parameters showed consistent results (Supplemental Table 4 ). In addition, the results did not change substantially after cases with other genes were excluded (ATP1A1, ATP2B3, CACNA1D, and CTNNB1) in a sensitivity analysis (Supplemental Table 5 ).
Differences in histopathological features and MC2R mRNA expression between KCNJ5-mutated and WT APAs
The histopathological characteristics of the cases examined are summarized in Fig. 1 and Table 4 . The KCNJ5-mutated group had a higher prevalence of APAs predominantly composed of clear cells [zona fasciculata (ZF)-like cells] than the KCNJ5 WT group. Ten cases (13%) in the KCNJ5-mutated group were composed of mixed cell types, harboring morphological intratumoral heterogeneity. Among 76 cases in the KCNJ5-mutated group, no case showed a dominance of compact cells [zona glomerulosa (ZG)-like cells], whereas six cases (24%) in the KCNJ5 WT group harbored a predominance of ZG-like cells. In addition, the prevalence of CYP11B1-positive and CYP17-positive tumor cells was higher in the KCNJ5-mutated group than in the KCNJ5 WT group. Thirteen cases were immunohistochemically negative for HSD3B2 in the KCNJ5-mutated group, although all of these cases were positive in the KCNJ5 WT group. Semiquantification of immunoreactivity of CYP11B1 and CYP17 in tumor cells also demonstrated a positive association with the presence of KCNJ5 mutations after adjustments for age, sex, and tumor size (Supplemental Table 6 ). An additional analysis estimating the relationship of immunoreactivity with endocrine parameters showed that most of the parameters associated with KCNJ5 mutations were associated with the immunoreactivity status of CYP11B1 in tumor cells (Supplemental Table 7 ). We found higher PAC/ACTH levels at 8:00 AM and higher PACs after the SIT/PAC at 8:00 AM in cases in which CYP11B1 and CYP17 immunoreactivity was pronounced. PAC after the DST/PAC at 8:00 AM showed an inverse association with CYP11B1 immunoreactivity. There was no significant difference in MC2R mRNA expression levels between the KCNJ5-mutated and KCNJ5 WT groups (Supplemental Table 1 ).
Discussion
In this study, we assessed the clinical responsiveness of PAC to the RAS and ACTH pathways in patients with APAs with or without KCNJ5 mutations. According to our results, PAC after the DST demonstrated a significant inverse association with the presence of KCNJ5 mutations, whereas PAC after the SIT did show a positive association in the multivariable analysis. These associations were indeed maintained even after the exclusion of other mutations in the tumors examined (ATP1A1, ATP2B3, CACNA1D, and CTNNB1) and were consistent with histopathological evaluation of the resected tumors.
Our results clearly indicated the potential hyperresponsiveness of PAC to endogenous ACTH in APAs harboring KCNJ5 mutations, highlighting the importance of estimating the DST in addition to other confirmatory tests such as the SIT for clinically predicting the presence of KCNJ5 mutations in tumors. Because KCNJ5-mutated cases represent the clinically pronounced phenotype of PA (12) and may greatly benefit from adrenalectomy (13) , predicting the presence of KCNJ5 mutations preoperatively in patients with PA is important. Of particular interest, the difference in PAC at baseline between the KCNJ5-mutated and KCNJ5 WT groups was eliminated after the DST because of marked suppression of the PAC by dexamethasone. In addition, PAC after the DST demonstrated a significant inverse association with KCNJ5 mutations after adjustments for PAC after the SIT and/or PAC at baseline, whereas PAC after the SIT showed a positive association with KCNJ5 mutations in the multivariate analyses. Considering the roles of the SIT in suppressing the RAS pathway (22) and of the DST in suppressing endogenous ACTH (23), these results indicate that compared with KCNJ5 WT APAs, KCNJ5-mutated APAs can have a pronounced response to the ACTH pathway for aldosterone hypersecretion rather than to the RAS pathway. The higher PAC/F after ACTH stimulation in the KCNJ5-mutated group on both peripheral blood sampling and AVS (at the affected side) supports this idea, as does the decreased PAC difference between the two groups from 8:00 AM to 11:00 PM. Previous studies estimated the clinical characteristics and predictive factors of KCNJ5 mutations (12, 24, 25) . Our study on Japanese patients with APAs demonstrated more females, larger tumor sizes, and a higher PAC in the KCNJ5-mutated group than in the KCNJ5 WT group, findings consistent with those of a previous meta-analysis (12) . Recently, a study of steroid profiles of blood samples from patients with AVS reported on characteristic genetic mutations in APAs before surgery (14) . They described 18-oxocortisol, which is related to the ACTH pathway, as a useful marker to predict KCNJ5 mutations in the APA group (14) . In general, KCNJ5 mutations result in the loss of K + channel selectivity, affecting cell proliferation (26) . Therefore, the presence of these mutations increases Na + conductance and intracellular Ca 2+ through cell depolarization, resulting in CYP11B2 overexpression and aldosterone hypersecretion (9) . We hypothesized that the ACTH pathway in the KCNJ5-mutated APAs may be more sensitive and/ or activated because there is no additional space for response to angiotensin II as a result of the full activation of downstream signaling by the RAS pathway. Further assessment with both molecular and clinical studies is warranted to establish the precise etiology of these mutated tumors. An immunohistochemical analysis in our present study revealed that the KCNJ5-mutated group contained a higher number of APAs that were composed predominantly of ZFlike cells and were positive for CYP11B1 and CYP17 than the KCNJ5 WT group did. Previous reports indicated that KCNJ5-mutated APAs tended to be large (12) and that CYP11B1 immunoreactivity was higher in larger APAs (27) , which agrees with our results suggesting hybrid cells in KCNJ5-mutated APAs.
The semiquantification of CYP11B1 and CYP17 immunoreactivity also revealed a positive association with the presence of KCNJ5 mutations in the multivariable logistic regression analysis after adjustments for age and tumor size. Both CYP11B1 and CYP17 played pivotal roles in the biosynthesis of cortisol (19, 28) , and some limited studies described the possibility that cortisol production in APA is related to the semiquantified immunoreactivity of CYP17 (29, 30) . Considering that there were no differences in the F between the KCNJ5-mutated and WT groups after the DST in our present study, differences in the immunoreactivity of these enzymes may be affected by more than cortisol biosynthesis. We assumed that the potential hypersensitivity and/or hyperactivity of the ACTH pathway in KCNJ5-mutated APAs also accounted for these differences. The negative relationship of the PAC with only the immunoreactivity of CYP11B1 after the DST/PAC at 8:00 AM in our present study supports this hypothesis because CYP11B1 contributes to both cortisol and aldosterone biosynthesis, whereas CYP17 contributes Figure 1 . Representative histological images of KCNJ5-mutated and KCNJ5 WT APAs. Both KCNJ5-mutated and KCNJ5 WT APAs were predominantly composed of clear cells, but a higher proportion of clear cells was observed in KCNJ5-mutated APAs. Immunoreactivity of CYP11B1 and CYP17 was more abundant in KCNJ5-mutated APAs than in KCNJ5 WT APAs. On the other hand, HSD3B2 immunoreactivity was more abundantly detected in KCNJ5 WT APAs than in KCNJ5-mutated APAs. CYP11B2 immunoreactivity was distinctly detected in both genotypes of APAs. H&E, hematoxylin and eosin.
to the production of cortisol and androgens but not aldosterone (15) .
Although a previous study showed relatively constant levels of CYP11B1 and CYP17 mRNA during the day in mouse adrenal glands (31), additional information regarding the circadian rhythmicity of the expression of these steroidogenic enzymes in humans would help clarify the underlying molecular mechanisms. In addition, almost all of our cases demonstrated positivity for HSD3B1 and HSD3B2, which take pivotal roles in the rate-limiting phase for aldosterone biosynthesis (32) , although a previous study reported absence of HSD3B1 in the adrenal grand (33) . Further investigation is required to clarify the biological significance of these subtypes in terms of aldosterone biosynthesis in APA.
We found no difference in MC2R mRNA expression levels that were dependent on KCNJ5 mutation status in our study. MC2R is known to be activated by ACTH and upregulates CYP11B2 (aldosterone synthase) (34) . Some previous studies reported elevated MC2R expression levels in APA tissues (35) (36) (37) . Given the high prevalence of KCNJ5 mutations in APAs, it remains possible that intracellular signal transduction of MC2R and its accessory protein (MRAP) is activated in KCNJ5-mutated APAs, although confirmation requires further investigation.
The present cross-sectional study has several limitations. First, because of the high frequency of KCNJ5 mutations in East Asia (24, 38) , the sample size in the KCNJ5 WT group was relatively small (n = 34), which enormously limited the selection of independent variables in our multivariable analysis. We therefore performed additional analyses after adjusting for other potential covariates and confirmed the similar results. Second, we did not consider mutations in other genes, such as ATP1A1, ATP2B3, CACNA1D, and CTNNB1, in the main analyses using clinical parameters because we focused on comparing cases with KCNJ5 mutations with others. The results did not substantially change after exclusion of these rare mutations in the additional analysis. Previous studies reported that ATPase-mutated and CACNA1D-mutated APAs tended to show the ZG phenotype, although KCNJ5-mutated APAs showed the ZF phenotype (11, 39) . These pathological differences imply that our findings might represent rather specific characteristics of KCNJ5 mutations, which requires further investigation. Third, we did not perform multisteroid analysis of mineralocorticoid and glucocorticoid pathways, information that could help estimate the contributions of ACTH and RAS pathways in aldosterone secretion in the KCNJ5-mutated and WT groups. Finally, because patients were selected from a single hospital on the basis of the availability of their resected adrenal samples and clinical endocrine parameters, the external validity of our results may be limited.
In conclusion, PAC was significantly suppressed after the DST in the KCNJ5-mutated group compared with the KCNJ5 WT group. Our results indicated that APAs harboring KCNJ5 mutations may be in the hyperresponsive state to endogenous ACTH compared with those without KCNJ5 mutations. Further studies from multiple institutions are required to validate our results and clarify the clinical effectiveness of the DST for predicting KCNJ5 mutations in patients with APA. 
